Article information
RESUMO
No presente artigo de revisão o autor aborda a terapêutica do carcinoma pulmonar nao de pcquenas células em função do estádio de apresentação da doença, dando especial relevo à sua abordagem multidisciplinar, no sentido de ultrapassarmos o mau prognóstico que o seu diagnóstico ainda acarreta.
Discute o Iugar das diferentes modalidades terapêuticas, a terapeutica da recidiva e da progressão tumorais, a do cancro do pulmao no doente idoso, o papel dos novos fármacos e as potencialidades dos novos alvos terapêuticos a nivel da biologia celular e molecular.
REV PORT PNEUMOL 2002; Vlll (3): 237-259
Palavras-chave:
carcinoma do pulmão
terapêutica
ABSTRACT
In the present paper, the author reviews the non-small-cell lung cancer treatment by stages of disease.
He states about the therapeutic strategies involving surgery, radiation therapy and chemotherapy, the important role of the multimodality approach of the patients, the relapsing and refractory tumor, the elderly patient, the new drugs, and the potential role of new gene and cell -based therapies.
REV PORT PNEUMOL 2002; VIII (3): 237-259
Key-words:
Lung cancer
therapeutic
Full text is only aviable in PDF
BIBLIOGRAFIA
[1.]
K.S. Albain, H.I. Pass.
Induction Therapy for Locally Advanced Non-Small-Cell Lung Cancer.
Lung Cancer, 2, pp. 798-820
[2.]
K. Albain, V. Rusch, J. Crowley, et al.
Long-Term Survival after Concurrent Cisplatin/Etoposide (PE) plus Chest Radiotherapy (RT) followed by Surgery in Bulky, Stages III A (N2) and 1118 Non-Small-Cell Lung Cancer (NSCLC): 6-Year Outcomes from Southwear Oncology Group Study 8805.
Proc ASCO, 18 (1999), pp. 467a
[3.]
American Joint Committee on Cancer.
AJCC Cancer Staging Handbook, 5, Lippincott-Raven, (1998),
[4.]
American Society of Clinical Oncology.
Clinical Practice Guidelines for the Treatment of Unresectable Non-Small-Cell Lung Cancer.
J Clin Oneal, 15 (1997), pp. 2996-3018
[5.]
American Thoracic Society/European Respiratory Society.
Pretreatment Evaluation of Non-Small-Cell Lung Cancer.
Am J Respir Crit Care Med, 156 (1997), pp. 320-332
[6.]
American Thoracic Society.
Clinical Practice Guidelines for the Treatment of Unrcsectable Non -Small-Cell Lung Cancer.
J Clin Oneal, 15 (1997), pp. 2996-3018
[7.]
A. Ardizzoni, F. Grossi, T. Scolaro, et al.
Induction Chemotherapy followed by Concurrent Standard Radiotherapy and Daily Low-Dose Cisplatin in Locally Advanced Non-Small-Cell Lung Cancer.
Br J Cancer, 81 (1999), pp. 310-315
[8.]
H. Asamura, M. Ando, Y. Matsuno, et al.
Histopathologic Prognostic Factors in Resected Adenocarcinomas. Is Nuclear DNA Content Prognostic?.
Chest, 115 (1999), pp. 1018-1024
[9.]
J.W. Asaph, J.F. Keppel, J.R. Handy, et al.
Surgery for Second Lung Cancers.
Chest, 11 (2000), pp. 1621-1625
[10.]
E.H. Baldini, M.M. Decamp, M.S. Kail, et al.
Patterns of Recurrence and Outcome for Patients with Clinical Stage II Non-S mall-Cell Lung Cancer.
Am J Clin Oncol, 22 (1999), pp. 8-14
[11.]
R.K. Batra, S. Sharma, S. Dubinett.
New Gene and Cell-Based Therapies for Lung Cancer.
Semin Respir Crit Care Med, 21 (2000), pp. 463-472
[12.]
C.P. Belani.
Combined Modality Therapy for Unresectable Stage III Non-Small-Cell Lung Cancer.
New Chemotherapy Combinations. Chest, 117 (2000), pp. 127S-132S
[13.]
C.P. Belani, R.K. Ramanathan.
Combined Modality Ttreatment of Locally Advanced Non-Small -Cell Lung Cancer. Incorporation of Novel Chemotherapeutics Agents.
Chest, I (1998), pp. 53S-60S
[14.]
S. Blackwell, J. Crawford.
Treatment of NonSmall-Cell Lung Cancer in the Elderly Patient.
Lung Cancer, 2, pp. 1071-1080
[15.]
P.D. Bonomi.
Treatment of Stage IV Non-Small-Cell Lung Cancer.
Updates in Advances in Lung Cancer, pp. 56-72
[16.]
M. Borges, E. Teixeira, R. Sotto-Mayor, et al.
Docetaxel como Quimioterapia de Segunda Linha no Carcinoma Pulmonar de Não Pequenas Células.
Rev Port Pneumol, VI (2000), pp. 551
[17.]
P. Bretcha-Boix, R. Rami-Porta, M. Mateu-Navarra, et al.
Surgical Treatment of Lung Cancer with Adrenal Metastasis.
Lung Cancer, 27 (2000), pp. 101-105
[18.]
H. Bülzebruck, R. Bopp, Drings Petal.
New Aspects in Staging of Lung Cancer: Prospective Validation of the International Union Against Cancer TNM Classification.
Cancer, 70 (1992), pp. 1102-1111
[19.]
P.A. Bunn, K. Kelly.
New Combinations in the Treatment of Lung Cancer.
A Time for Optimism. Chest, 117 (2000), pp. 138S-143S
[20.]
P.A. Bunn, J. Mault, K. Kelly.
Adjuvant and Neoadjuvant Chemotherapy for Non-Small-Cell Lung Cancer. A Time for Reassessment?.
Chest, 117 (2000), pp. 19S-122S
[21.]
P.A. Bunn, A. Soriano, G. Johnson, et al.
New Therapeutic Strategies for Lung Cancer. Biology and Molecular Biology Come of Age.
Chest, 117 (2000), pp. 163S-168S
[22.]
R. Cameron, J. Fringer, C. Taylor, R. Gilden, et al.
Practice Guidelines for Non-Small-Cell Lung Cancer.
Cancer Journ, 2 (1996), pp. S61-S68
[23.]
F. Cappuzzo, A. Zappala, T. Le Chevalier.
Should all Stage IV Non-S mall Cell-Lung Cancer Be Treated Palliatively?.
Progress and Perspectives in the Treatment of Lung Cancer, pp. l83-l189
[24.]
A.E. Chang.
Multidisciplinary Cancer Clinics: Their Ti me has Come.
J Surg Oncol, 69 (1998), pp. 203-205
[25.]
R.J. Cote, E.J. Beattie, B. Chaiwun, et al.
Detection of Occult Bone Marrow Micrometastases in Patients with Operable Lung Carcinoma.
Ann Surg, 222 (1995), pp. 415-425
[26.]
G. Cox, U. Jones, A. Andi, et al.
Molecular Staging for Operable Non-Small-Cell Lung Cancer.
Proc ASCO, 19 (2000), pp. 482a
[27.]
G. Cullen, U. Billingham, C.M. Woodroffe, et al.
Mitomycin, Ifosfamide and Cisplatin in Unresectable Non-Small-Cell Lung Cancer: Effects on Survival and Quality of Life.
J Clin Oncol, 17 (1999), pp. 194
[28.]
W. Curran Jr..
New Therapeutic Strategies In volving Radiation Therapy for Patients with Non-Small-Cell Lung Cancer.
Chest, 107 (1995), pp. 302S-305S
[29.]
A. Depierre.
Progress in Chemotherapy in Advanced Non-Small-Cell Lung Cancer.
Lung Tumors, pp. 567-581
[30.]
J. Deslauriers, J. Grégoire.
Surgical Therapy of Early Non-Small-Cell Lung Cancer.
Chest, 117 (2000), pp. 104S-109S
[31.]
F.C. Detterbeck, T.M. Eagan.
Surgery for Stage II Non-Small-Cell Lung Cancer.
Diagnosis and Treatment of Lung Cancer, pp. 191-197
[32.]
F.C. Detterbeck, D.R. Jones.
Surgical Treatment of Stage IIIA (N2) Non-Small-Cell Lung Cancer.
Diagnosis and Treatment of Lung Cancer, pp. 244-256
[33.]
P.C. Detterbeck, A.C. Kiser.
T3 Non-Small-Cell Lung Cancer (Stage IIB-IIIA).
Diagnosis and Treatment of Lung Cancer, pp. 223-232
[34.]
F.C. Detierbeck, M.A. Socinski.
Induction Therapy and Surgery for I-IIIA, B. Non-Small-Cell Lung Cancer.
Diagnosis and Treatment of Lung Cancer, pp. 267-282
[35.]
R.O. Dillmann, S.L. Seagren, K.J. Propert, et al.
A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation Versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer.
N Engl J Med, 323 (1990), pp. 940-945
[36.]
R.O. Dilmann, S.L. Seagren, J. Herndon, et al.
Improved Survival in Stage III Non-Small-Cell Lung Cancer: Seven Year Follow-up of CALGB 8433.
J Nal Cancer-Inst, 88 (1996), pp. 1210-1215
[37.]
D.E. Dosoretz, M.J. Katin, P.H. Blitzer, et al.
Medically Inoperable Lung Carcinoma: The Role of Radiation Therapy.
Semin Radiation Oncol, 6 (1996), pp. 98-104
[38.]
P. Dumont, B. Gasser, C. Rouge, et al.
Bronchoalveolar Carcinoma. Histopathologic Study of Evolution in a Series of I 05 Surgically Treated Patients.
Chest, 113 (1998), pp. 391-395
[39.]
C.C. Earle, J.S. Tsai, R.D. Gelber, et al.
Effectiveness of Chemotherapy for Advanced Lung Cancer in the Elderly: Instrumental Variable and Propensity Analysis.
J Clin Oncol, 19 (2001), pp. 1064-1070
[40.]
E.S. Edell, D.A. Cortese.
Photodynamic Therapy for Lung Cancer.
Lung Tumors, pp. 523-535
[41.]
E.J. Emannuel, L.L. Emannuel.
Four Models of the Physician-Patient Relationship.
JAMA, 267 (1992), pp. 2221-2226
[42.]
W.K. Evans.
Chemotherapy benefit and costeffectiveness of treatment for advanced lung cancer.
Lung Cancer, 18 (1997), pp. 68-69
[43.]
E. Felip, R. Rosell.
Is the Evidence in Favour of Neoadjuvant Chemotherapy in Stage ll!A (N2) Non Small-Cell Lung Cancer Solid Enough?.
Monaldi Arch Chest Dis, 55 (2000), pp. 305-310
[44.]
C. Fernandez, R. Rosell, A. Abad-Esteve, et al.
Quality of Life During Chemotherapy in Non-Small-Cell Lung Cancer Patients.
Acta Oncol, 28 (1989), pp. 29-33
[45.]
F.V. Fossella.
Second-Line Chemotherapy for NonSmall-Cell Lung Cancer.
Lung Cancer, 2, pp. 903-909
[46.]
D.R. Gandara, B. Leigh, E. Vallieres, et al.
Preoperative Chemotherapy in Stage III Non-Small-Cell Lung Cancer: Long-Term Outcome.
Lung Cancer, 26 (1999), pp. 1-6
[47.]
L. Gaspar, E. Teixeira, R. Soito-Mayor, et al.
Combined Chemoradiation Treatment in Stage III NonSmall-Cell Lung Cancer.
Radiotherapy and Oncology, 43 (1997), pp. S199
[48.]
L. Gaspar, E. Teixeira, R. Sotio-Mayor, et al.
Radioterapia Radical no Cancro do Pulmão Medicamcnte Inoperável.
Rev Port Pneumol, VI (2000), pp. 539
[49.]
L.F.L. Gaspar, R.M.C. Susano, M. Ortiz, et al.
Sequential Chemotherapy and Radiotherapy in Non-SmallCell Lung Cancer.
Lung Cancer, 29 (2000), pp. 101
[50.]
R.J. Ginsberg, J.L. Port.
Surgical Therapy of Stage I and Non-T3No Stage II Non-Small-Cell Lung Cancer.
Lung Cancer, 2, pp. 682-693
[51.]
S.L. Graziano, G.P. Gamble, N.B. Newman, et al.
Prognostic Significance of K-ras Codon 12 Mutations in Patients Resected Stage I and II Non-Small-Cell Lung Cancer.
J Clin Oncol, 17 (1999), pp. 668-675
[52.]
F.A. Greco, J.D. Hainsworth.
Multidisciplinary Approach to Potentially Curable Non-Small-Cell Carcinoma of the Lung.
Oncology, 11 (1997), pp. 27-36
[53.]
C. Gridelli.
The ELVIS Trial: A Phase III Study of Single-Agent Vinorelbine as First-Line Treatment in Elderly Patients with Advanced Non-Small-Cell Lung Cancer.
The Oncologist, 6 (2001), pp. 4-7
[54.]
G. Gross, L. Paszat, T.E. Newman, et al.
Usc of preoperative chemotherapy with or without postoperative radiotherapy in technically resectable stage IIIA nonsmall-cell lung cancer.
Cancer Prevent Control, 2 (1996), pp. 32-39
[55.]
Lung Cancer Therapy: Annual 2000, pp. 91-104
[56.]
T.A. Hensing, J.S. Halle, M.A. Socinski.
Chemoradiothcrapy for Stage IIIA, B Non-Small-Cell Lung Cancer.
Diagnosis and Treatment of Lung Cancer, pp. 291-303
[57.]
C.L. Henschke, O.I. Mccauley, D.F. Yankeleyitz, et al.
Early Lung Cancer Action Project: Overall Design and Findings from Baseline Screening.
Lancet, 354 (1999), pp. 99-105
[58.]
R.S. Herbest, I.J. Fidler.
Prognostic Markers of Metastasis and Angiogenesis in Early-Stage Non-Small-Cell Lung Cancer.
ASCO, pp. 13-22
[59.]
E.C. Holmes.
Treatment of Stage II Lung Cancer (TlNl and T2N l).
Surg Clin North Am, 67 (1987), pp. 945-949
[60.]
C. Huisman, G. Giaccone, P.E. Postmus.
Second -Line Chemotherapy in Relapsing or Refractory Non-Small-Cell Lung Cancer: A Review.
J Clin Oncol, 18 (2000), pp. 3722-3730
[61.]
Mainen L. Jaakki, P.J. Goodwin, J. Pater, et al.
Counting the Costs of Chemotherapy in a National Cancer Institute of Canada Randomized Trial in Non-Small -Cell Lung Cancer.
J Clin Oncol, 8 (1990), pp. 1301-1309
[62.]
M.T. Jaklitsch, R. Bueno, S.J. Swanson, et al.
New Surgical Options for Elderl y Lung Cancer Patients.
Chest, 116 (1999), pp. 480S-485S
[63.]
J.R. Jett.
Screening for Lung Cancer in High-Risk Groups: Current Status of Low-Dose Spiral CT Scanning and Sputum Markers.
Semin Respir Crit Care Med, 21 (2000), pp. 385-392
[64.]
D.H. Johnson.
Locally Advanced Unresectable Non -Small-Cell Kung Cancer.
New Treatment Strategies. Chest, 117 (2000), pp. 123S-126S
[65.]
D.H. Johnson, I.A.T. Turris.
Combined Modality Treatment for Locally Advanced, Unrescctable NonSmall-Cell Lung Cancer.
Lung Cancer, 2, pp. 910-920
[66.]
O.I.I. Johnson, J. Zhu, J. Schiller, et al.
E1594- A Randomized Phase Ill Trial in Metastatic Non-SmallCell Lung Cancer (NSCLC) - Outcome of PS 2 Patients (pts): An Eastern Cooperative Group Trial (ECOG).
Proc ASCO, 18 (1999), pp. 461a
[67.]
H. Johnson, J.S. Halle.
Radiotherapy for Stage I, II Non-Small-Cell Lung Cancer.
Diagnosis and Treatment of Lung Cancer, pp. 198-205
[68.]
D.R. Jones, F.C. Detterbeck.
Surgery for Stage I Non-Small-Cell Lung Cancer.
Diagnosis and Treatment of Lung Cancer, pp. 177-190
[69.]
D.O. Karp.
Lung Cancer Chemoprevention and Management of Carcinoma in Situ.
Semin Oncol, 24 (1997), pp. 402-410
[70.]
M. Kaneko, K. Eguchi, H. Ohmatsu, et al.
Peripheral Lung Cancer: Screening and Detection with Low-Dose Spiral CT versus Radiography.
Radiology, 201 (1996), pp. 798-802
[71.]
D.O. Karp, A. Law.
Lung Cancer Chcmoprcvention and Management of Carcinoma in Situ.
Updates in Advances in Lung Canccr, pp. 1-20
[72.]
K. Kelly.
Future Directions for New Cytotoxic Agents in the Treatment of Advanced-Stage Non-Small-Cell Lung Cancer.
ASCO, pp. 357-367
[73.]
K. Kelly, P.A. Bunn Jr..
Is it Time to Reevaluate our Approach to the Treatment of 13rain Metastases in Patients with Non-Small-Cell Lung Cancer?.
Lung Cancer, 20 (1998), pp. 85-91
[74.]
R. Komaki.
Combined Chemotherapy and Radiation Therapy in Surgically Unresectable Regionally Advanced Non-Small-Cell Lung Cancer.
Semin Radiation Oncol, 6 (1996), pp. 86-91
[75.]
R. Komaki, R.C. Morice, G.L. Walsh.
High-Dose Rate After loading Endobronchial Brachytherapy.
Lung Cancer, Second, pp. 163-179
[76.]
R.J. Korst, R. Tsuchiya.
Treatment of Non-Small Cell Lung Cancer: Surgery.
Textbook of Lung Cancer, pp. 185-200
[77.]
M.G. Kris, S.A. Laurie, V.A. Miller.
Integrating New Agents and Approaches Into Chemotherapy Regimens for Non-Small-Cell Lung Cancer.
ASCO, pp. 368-374
[78.]
K.B. Kuiuscho, B. Passlick, I.Z.B. Icki Jr., et al.
Disseminated Tumor Cells in Lymph Nodes as a Determinant for Survivalio Surgically Resected Non-Small-Cell Lung Cancer.
J Clin Oncol, 17 (1999), pp. 19-24
[79.]
S. Lam, T. Kennedy, M. Unger, et al.
Localization of Brochial lntraepitelial Neoplastic Lesions by Fluorescence Bronchoscopy.
Chest, 113 (1998), pp. 696-702
[80.]
R.J. Landreneau, M.J. Mack, R.D. Dowling, et al.
The Role of Thoracoscopy in Lung Cancer Management.
Chest, 11 (1998), pp. 6S-12S
[81.]
E. Lartigau.
Hypoxic Cell Radiosensitizers: Past, Present and Future.
Concomitant Chemoradiation, pp. 250-257
[82.]
A.S. Laurie, M.G. Kris.
Single-Agent Docetaxel (Taxotere®) in the Treatment of Advanced Non-Small-Cell Lung Cancer: Clinical Concepts and Commentary.
Clinical Lung Cancer, I (2000), pp. S5-S9
[83.]
N. Leighl, M. Gattellari, P. Butow, et al.
Discussing Adjuvant Cancer Therapy.
J Clio Oncol, 19 (2001), pp. 1768-1778
[84.]
J.M. Lopez-Picazo, I. Azinovic, J.J. Aristu, et al.
Induction Platinum-Based Chemotherapy followed by Radical Hyperfractionated Radiotherapy with Concurrent Chemotherapy in the Treatment of Locally Advanced Non-Small-Cell Carcinoma of the Lung.
Am J Clio Oncol, 22 (1999), pp. 203-208
[85.]
P. Macchiarini, P. Dartewvelle.
Extended Resections for Lung Cancer.
Lung Cancer, Second, pp. 135-161
[86.]
J. Maçanita.
Actualização do Sistema lntcmacional de Estadiamento do Cancro do Pulmao.
Pneumologia Oncológica, pp. 101-105
[87.]
N. Martini, M. Bains, M. Burt, et al.
Incidence of Local Recurrence and Second Primary Tumors in Resected Stage I Lung Cancer.
J Thorac Cardiovasc Surg, 109 (1995), pp. 120-129
[88.]
N. Martini, M.G. Kris, R.G. Ginsberg.
The role of multimodality therapy in locorcgional non-small-cell lung cancer.
Surg Oncol Clin North Am, 6 (1997), pp. 769-791
[89.]
R.J. Mckenna Jr., R.K. Wolf, M. Brenner, et al.
Is Lobectomy by Video-assisted Thoracic Surgery an Adequate Cancer Operation?.
Ann Thorac Surg, 66 (1998), pp. 1903-1908
[90.]
K.D. Miller, C.J. Sweeney, G.W. Sledge.
Redefining the Target: Chemotherapeutics as Antiangiogcnics.
J Clin Oncoi, 19 (2001), pp. 1195-1206
[91.]
N. Miyagj, T. Miki, Y. Jtoh, et al.
Radiotherapy for Adrenal Gland Metastasis from Lung Cancer: Report of Three Cases.
Radial Mcd, I7 (1999), pp. 71-75
[92.]
K. Mori, K. Tominagu, T. Hirose, et al.
Utility of Low-Dose Helical CT as a Second Step after Plain Chest Radiography for Mass Screening for Lung Cancer.
J Thorac Imaging, 12 (1997), pp. 178-180
[93.]
F. Mornex, P. Van HOutte, O. Chapet.
Locally Advanced Non-Small·Ccll Lung Cancer: The Role of Ncoadjuvant or Definitive Chcmoradiation.
Concomitant Chcmoradiation. Current Status and Future, pp. 106-120
[94.]
C.F. Mountain.
Revisions in the International System for Staging Lung Cancer.
Chest, III (1997), pp. 1710-1717
[95.]
J.L. Mulshine, F. Scott, J. Zhou, et al.
Development of Molecular Approaches to Early Lung Cancer Detection.
Semin Radiation Oncol, 6 (1996), pp. 72-75
[96.]
Non-Small-Cell Lung Cancer Collaborative Group.
Chemotherapy in Non-Small-Cell Lung Cancer: A Meta-Analysis using Updated Data on Individual Patients from 52 Randomiscs Clinical Trials.
Br Med J, 311 (1995), pp. 899-909
[97.]
M. Okada, N. Tsubota, M. Yoshimura, et al.
Induction Therapy for Non-Small-Cell Lung Cancer with Involved Mediastinal Nodes in Multiple Stations.
Chest, 118 (2000), pp. 123-128
[98.]
U. Pastorino, M. Infante, M. Maioli, et al.
Adjuvant Treatment of Stage I Lung Cancer With High-Dose VitaminA.
J Clin Oncol, II (1993), pp. 1216-1222
[99.]
K. Patel, J. Izbicki, B. Psslick, et al.
Frequency and Prognostic Significance of Isolated Tumour Cells in Bone Marrow of Patients with Non-Small Lung Cancer Without Overt Metastases.
Lancet, 347 (1996), pp. 649-653
[100.]
M. Patelli, L. Agli, V. Poletti, et al.
Photodynamic Laser Therapy for the Treatment of Early-Stage Bronchogenic Carcinoma.
Monaldi Arch Chest Dis, 54 (1999), pp. 315-318
[101.]
K. Peck, Y.-P. Sher, J.-Y. Shih, et al.
Detection and Quantification of Circulating Cancer Cells in the Peripheral Blood of Lung Cancer Patients.
Cancer Res, 58 (1998), pp. 2761-2765
[102.]
M.C. Perry, J. Deslauries, K.S. Albain, et al.
Induction Treatment for Resectable Non-Small Lung Cancer. A Consensus Report.
Lung Cancer, 17 (1997), pp. 15-18
[103.]
K.M. Pisters, R.J. Ginsberg, D.J. Giroux, et al.
Induction Chemotherapy before Surgery for Early-Stage Lung Cancer: A Novel Approach. Bimodality Lung Oncolgy Team.
J Thorac Cardiovasc Surg, 119 (2000), pp. 429-439
[104.]
J.L. Pujol, T. Lafontaine, X. Quantin, et al.
Neoadjuvant Etoposide, Ifosfamide, and Cisplatin Followed by Concomitant Thoracic Radiotherapy and Continuos Cisplatin Infusion in Stage IIIB Non-Small-Cell Lung Cancer.
Chest, 115 (1999), pp. 144-149
[105.]
A.L. Rafanon, A.C. Meheta.
Role of Bronchoscopy in Lung Cancer.
Semin Respir Crit Care Mcd, 21 (2000), pp. 405-420
[106.]
M.S. Reif, P. Rivera.
Evidence-Based Outcomes for Patients with Advanced Non-Small Cell Lung Cancer.
Semin Respir Crit Care Med, 21 (2000), pp. 443-449
[107.]
M.S. Reif, M.A. Socinski, M.P. Rivera.
EvidenceBased Medicine in the Treatment of Non-Small-Cell Lung Cancer.
Clin Chest Med, 21 (2000), pp. 107-120
[108.]
R. Rosell, J. Gomez-COdina, C. Camps, et al.
A randomized trial comparing preoperative chemotherapy plus surgery alone in patients with non-small-cell lung cancer.
N Engl. J Med, 330 (1994), pp. 153-158
[109.]
R. Rosell, J. Gomez-Codina, C. Camps, et al.
Pre-resectional Chemotherapy in Stage III A Non-Small-Cell Lung Cancer: a 7-Year Assessement of a Randomized Controlled Trial.
Lung Cancer, 26 (1999), pp. 7-14
[110.]
J.A. Roth.
Genetic Manipulations for Treatment of Lung Cancer.
Lung Cancer, Second Edition, pp. 369-381
[111.]
J.A. Roth, E.N. Atkinson, F. Fossela, et al.
LongTerm Follow-Up of Patients Enrolled in a Randomized Trial Comparing Perioperativc Chemotherapy and Surgery with Surgery Alone in Resectable Stage IIIA NonSmall-Cell Lung Cancer.
Lung Cancer, 21 (1998), pp. 1-6
[112.]
J.A. Roth, F. Fossella, R. Komaki, et al.
A randomized trial comparing perioperative chemotherapy and surgery alone in resectable stage III A non-small-cell lung cancer.
J Natl Cancer Inst, 86 (1994), pp. 673-680
[113.]
J.A. Roth, T. Mukhopadhyay, W.W. Zhang, et al.
Gene Replacement Strategies for Lung Cancer.
Semin Radiation Oncol, 6 (1996), pp. 105-109
[114.]
V.W. Rusch.
Surgical Treatment of Patients with N2 Disease.
Semin Radiation Oncol, 6 (1996), pp. 76-85
[115.]
V.W. Rusch.
Evidence-Based Outcomes for Patients with Non-Small-Cell Lung Cancer Undergoing Resection.
Semin Respir Crit Care Med, 21 (2000), pp. 433-441
[116.]
J.J. Rusthoven, E. Eisenhauer, C. Butts, et al.
Multitargeted Anti folate LY231514 as First-Line Chemotherapy for Patients with Advanced Non-Small-Cell Lung Cancer: A Phase II Study.
J Clin Oneal, 17 (1999), pp. 1194-1199
[117.]
W.T. Sause, A. Gregor.
Treatment of NSCLC: Radiotherapy.
Textbook of Lung Cancer, pp. 201-212
[118.]
G. Scagliotti, S. Novello.
New Drugs for New Chemotherapy Standards.
Lung Tumors, pp. 657-678
[119.]
J.H. Schiller.
Chemotherapy for Advanced NonSmall-Cell Lung Cancer.
Lung Cancer. Principles and Practice, 2, pp. 502-889
[120.]
M. Schuler, R. Herrman, J. de Greve, et al.
Adenovirus-Mediated Wild-Type p53 Gene Transfer in Patients Receiving Chemotherapy for Advanced NonSmall-Cell Lung Cancer: Results of a Multicenter Phase II Study.
J Clin Oncol, 19 (2001), pp. 1750-1758
[121.]
S. Sharma, Whited, R. Imandl, et al.
Development of Inhalational Agents for Oncologic Use.
J Clin Oneal, 19 (2001), pp. 1839-1847
[122.]
F.A. Shepherd, O.N. Carney.
Treatment of NSCLC: Chemotherapy.
Textbook of Lung Cancer, pp. 213-242
[123.]
F.A. Shepherd, J. Dancey, R. Ramliau, et al.
Prospective Randomized Trial of Docetaxcl versus Best Supportive Care in Patients with Non-Small-Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy.
J Clin Oncol, 18 (2000), pp. 2095-2103
[124.]
J.M. Siegfried.
Biology and Chemoprevention of Lung Cancer.
Chest, 113 (1998), pp. 40S-45S
[125.]
S.F. Slovin, H.I. Scher.
Detectable Tumor Cells in the Blood and Bone Marrow: Smoke or Fire?.
Cancer, 83 (1998), pp. 394-398
[126.]
I.E. Smith, M.E.R. O‘Brien, D.C. Talbot, et al.
Duration of Chemotherapy in Advanced Non-Small-Cell Lung Cancer: A Randomized Trial of Three Versus Six Courses of Mitomycin, Vinblastine, and Cisplatin.
J Clin Oncol, 19 (2001), pp. 1336-1343
[127.]
M.A. Socinskl.
Chemotherapy for Stage IV NonSmall-Cell Lung Cancer.
Diagnosis and Treatment of Lung Cancer, pp. 307-325
[128.]
M.A. Socinski, F.C. Detterbeck, J.G. Rosenmam.
Adjuvant Therapy of Rescted Non-Small Cell Lung Cancer.
Diagnosis and Treatment of Lung Cancer, pp. 206-219
[129.]
J.-C. Soria, T. Le Chevalier, C. Le Pechoux, R. Arriagada.
Multimodality Therapy in Locally Advanced Non-Small-Cell Lung Cancer (NSCLC Stage 1118), pp. 553-565
[130.]
R. Sotto-Mayor.
A Terapêutica no Carcinoma Brônquico de não Pequenas Células.
Arq SPPR, II (1994), pp. 259-274
[131.]
R. Sotto-Mayor.
Argumentos a Favor da Prescrção da Quimioterapia (Qt) no Carcinoma Pulmonar de Não Pequenas Celulas (CPNPC).
Rev Port Pneumal, III (1997), pp. 265-282
[132.]
R. Sotto-Mayor.
Terapêutica Génica do Cancro do Pu1mão.
Pneumologia Oncológica, pp. 227-236
[133.]
R. Sotto-Mayor.
Quimioterapia do CPNPC: Dados Actuais para uma Sfntese do Tema.
Rev Port Pneumol, VI (2000), pp. 687-690
[134.]
R. Sotto-Mayor.
Poluição e Cancro do Pulmãlo.
Ambiente Urbano e Saude (IV) A Cidade, o Clima e as Cidades, pp. 111-131
[135.]
R. Sotto-Mayor.
Progressos Terapêuticos no Cancro do Pulmão.
Perspectiva Actual e Futura, pp. 23-46
[136.]
R. Sotto-Mayor, R. Nascimento, J. Duarte, et al.
Cancro do Pulmilo: Revisao de 230 Casos.
Livro de Resumos (Comunicações Orais), (1985),
[137.]
S.G. Swisher, J.A. Roth, J. Nemunaitis, et al.
Adenovirus-Mediated p53 Gene Transfer in Advanced Non Small-Cell Lung Cancer.
J Natl Cancer lnst, 91 (1999), pp. 763-771
[138.]
M. Taulelle, P. Vincent, R. Garcia, et al.
Endobronchial Brachytherapy.
Lung Tumors, pp. 537-552
[139.]
E. Teixeira.
Controversias no Cancro do Pulmao (II).
Terapeutica, pp. 115-131
[140.]
E. Teixeira, R. Sotto-Mayor, M. Borges, et al.
Combination Chemotherapy with Cisplatin, lfosfamid and Etoposide (PIE) and Whole Brain Radiotherapy (WBR) for Patients with Non-Small Cell Lung Cancer (NSCLC) with Brain Metastases.
Eur Resp J, 12 (1998), pp. 414S
[141.]
E. Teixeira, R. Sotto-Mayor, M. Borges, et al.
Docetaxel in Patients with Non-Small-Cell Lung Cancer Relapsed or Progressed after First-Line Chemotherapy.
Eur Resp J, 31 (2000), pp. 16
[142.]
M.S. Tockman, P.K. Gupta, J.D. Myars, et al.
Sensitive and Specific Monoclonal Antibody Recognition of Human Lung Cancer Antigen on Preserved Sputum Cells: A New Approach to Early Lung Cancer Detection.
J Clin Oncol, 6 (1988), pp. 1685-1693
[143.]
C.M. Tsai, K.T. Chang, J.Y. Chen, et al.
Cytotoxic Effects of Gemcitabine-Containing Regimens Against Human Non-Small-Cell Lung Cancer Cell Lines Wich Express Different Levels of p185neu.
Cancer Res, 56 (1996), pp. 794-801
[144.]
J.F. Turner, K.-P. Wang.
Endobronchial Laser Therapy.
Clin Chest Med, 20 (1999), pp. 107-122
[145.]
U. Van Zandwijk, N. Pastorino, O. De VRIES, et al.
Randomized Trial of Chemoprevention with Vitamin A and N-Acetylcysteine in Patients with Cancer of the Upper and Lower Airways: the Euroscan Study.
Proc ASCO, 18 (1999), pp. 464a
[146.]
J.R. Vieira.
Broncoscopia de Intervenção no Cancro do Pulmao.
Pneumologia Oncológica, pp. 245-277
[147.]
E.E. Vokes, K.A. Leopold, J.E. Herndon, et al.
A Randomized Phase II Study of Gemcitabine or Paclitaxel or Vinorelbine with Cisplatin as Induction Chemotherapy (Ind CT) and Concomitant Chcmoradiotherapy (XRT) for Unresectable Stage III Non-Small-Cell Lung Cancer (NSCLC) (CALGB Study 9431).
Proc ASCO, 18 (1999), pp. 459a
[148.]
H. Wagner.
Postoperative Adjuvant Therapy for Patients With Resected Non-Small-Cell Lung Cancer: Still Controversial After all These Years.
Chest, 117 (2000), pp. 110S-118S
Copyright © 2002. Sociedade Portuguesa de Pneumologia/SPP
Special content about COVID-19
- Hyperoxemia in invasively ventilated COVID–19 patients–Insights from the PRoVENT–COVID study
- Association between respiratory distress time and invasive mechanical ventilation in COVID-19 patients: A multicentre regional cohort study
- Assisted mobilisation in critical patients with COVID-19
- Two years of COVID-19: Trends in rehabilitation
Recommended
articles
articles
Pulmonol. 2024;30:214-21
Pulmonol. 2024;30:239-46
10.1016/j.pulmoe.2024.02.002
Open access
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publish in
Pulmonology
Pulmonology
- Home
- All contents
- Publish your article
- About the journal
- Metrics
- Open access
Article options